@article{johnson:hal-03194617,
TITLE = {Rovalpituzumab Tesirine as a Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Patients With Extensive-Stage Small Cell Lung Cancer: Results From the Phase 3 MERU Study},
AUTHOR = {Johnson, Melissa L and Zvirbule, Zanete and Laktionov, Konstantin and Helland, Aslaug and Cho, Byoung Chul and Gutierrez, Vanesa and Colinet, Beno{\^i}t and Lena, Herve and Wolf, Martin and Gottfried, Maya and Okamoto, Isamu and van Der Leest, Cor and Rich, Patricia and Hung, Jen-Yu and Appenzeller, Christina and Sun, Zhaowen and Maag, David and Luo, Yan and Nickner, Caroline and Vajikova, Alena and Komarnitsky, Philip and Bar, Jair},
URL = {https://hal.science/hal-03194617},
JOURNAL = {Journal of Thoracic Oncology},
PUBLISHER = {Lippincott, Williams \& Wilkins},
VOLUME = {16},
NUMBER = {9},
PAGES = {1570-1581},
YEAR = {2021},
MONTH = Sep, DOI = {10.1016/j.jtho.2021.03.012},
KEYWORDS = {Rovalpituzumab tesirine ; Small cell lung cancer ; Maintenance ; Phase 3 ; DLL3 ; Platinum-based chemotherapy},
PDF = {https://hal.science/hal-03194617/file/1-s2.0-S1556086421020670-main.pdf},
HAL_ID = {hal-03194617},
HAL_VERSION = {v1},
}